1.68
-0.035(-2.05%)
Currency In USD
Previous Close | 1.71 |
Open | 1.75 |
Day High | 1.77 |
Day Low | 1.67 |
52-Week High | 28.2 |
52-Week Low | 1.5 |
Volume | 366,131 |
Average Volume | 535,009 |
Market Cap | 5.63M |
PE | -0.04 |
EPS | -43.87 |
Moving Average 50 Days | 3.16 |
Moving Average 200 Days | 5.16 |
Change | -0.04 |
If you invested $1000 in Bionano Genomics, Inc. (BNGO) since IPO date, it would be worth $27.24 as of September 30, 2025 at a share price of $1.675. Whereas If you bought $1000 worth of Bionano Genomics, Inc. (BNGO) shares 5 years ago, it would be worth $4.29 as of September 30, 2025 at a share price of $1.675.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
GlobeNewswire Inc.
Sep 17, 2025 9:00 PM GMT
SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate of 5,000,000 shares of the Company’s common sto
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
GlobeNewswire Inc.
Sep 16, 2025 1:10 PM GMT
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the Company’s common stock (or common stock equ
Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology
GlobeNewswire Inc.
Sep 16, 2025 11:00 AM GMT
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesi